DK3271476T3 - Fremgangsmåder, værktøjer og systemer til vurdering, forebyggelse, styring og behandlingsvalg for type 2-diabetes - Google Patents

Fremgangsmåder, værktøjer og systemer til vurdering, forebyggelse, styring og behandlingsvalg for type 2-diabetes Download PDF

Info

Publication number
DK3271476T3
DK3271476T3 DK16710971.9T DK16710971T DK3271476T3 DK 3271476 T3 DK3271476 T3 DK 3271476T3 DK 16710971 T DK16710971 T DK 16710971T DK 3271476 T3 DK3271476 T3 DK 3271476T3
Authority
DK
Denmark
Prior art keywords
diabetes
assessment
tools
prevention
management
Prior art date
Application number
DK16710971.9T
Other languages
English (en)
Inventor
Mirella G Zulueta
Buela Laureano Simón
Original Assignee
Patia Biopharma S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patia Biopharma S A De C V filed Critical Patia Biopharma S A De C V
Application granted granted Critical
Publication of DK3271476T3 publication Critical patent/DK3271476T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK16710971.9T 2015-03-18 2016-03-18 Fremgangsmåder, værktøjer og systemer til vurdering, forebyggelse, styring og behandlingsvalg for type 2-diabetes DK3271476T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1504607.1A GB201504607D0 (en) 2015-03-18 2015-03-18 Methods,tools and systems for the assessment,preventation,management and treatment selection for type 2 diabetes
PCT/EP2016/055949 WO2016146811A1 (en) 2015-03-18 2016-03-18 Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes

Publications (1)

Publication Number Publication Date
DK3271476T3 true DK3271476T3 (da) 2020-06-08

Family

ID=53052023

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16710971.9T DK3271476T3 (da) 2015-03-18 2016-03-18 Fremgangsmåder, værktøjer og systemer til vurdering, forebyggelse, styring og behandlingsvalg for type 2-diabetes

Country Status (8)

Country Link
US (2) US20180094318A1 (da)
EP (1) EP3271476B1 (da)
JP (1) JP6751418B2 (da)
DK (1) DK3271476T3 (da)
ES (1) ES2794950T3 (da)
GB (1) GB201504607D0 (da)
MX (1) MX2017011910A (da)
WO (1) WO2016146811A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210254164A1 (en) * 2018-06-15 2021-08-19 Opti-Thera Inc. Polygenic risk scores for predicting disease complications and/or response to therapy
JP6688418B1 (ja) * 2019-04-16 2020-04-28 ジェネシスヘルスケア株式会社 ２型糖尿病のリスクを判定する方法
WO2021170504A1 (en) * 2020-02-25 2021-09-02 Ling Charlotte Dna methylation level of specific cpg sites for prediction of glycemic response and tolerance to metformin treatment in type 2 diabetic patients
CN113393896A (zh) * 2021-06-11 2021-09-14 成都果壳医学科技有限公司 一种基于深度神经网络的i型糖尿病风险评估系统
WO2024080651A1 (ko) * 2022-10-12 2024-04-18 서울대학교병원 Thada 마커를 이용한 설폰요소제 의존성 예측용 조성물 및 그 예측 방법
KR20240051814A (ko) * 2022-10-12 2024-04-22 서울대학교병원 Gipr 마커를 이용한 설폰요소제 의존성 예측용 조성물 및 그 예측 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210272B1 (en) 1997-12-22 2001-04-03 Health Hero Network, Inc. Multi-player interactive electronic game for health education
JP5033392B2 (ja) 2006-03-10 2012-09-26 国立大学法人三重大学 ２型糖尿病の遺伝的リスク検出法
US20090307179A1 (en) 2008-03-19 2009-12-10 Brandon Colby Genetic analysis
CA2767360A1 (en) * 2009-07-10 2011-01-13 Decode Genetics Ehf. Genetic markers associated with risk of diabetes mellitus

Also Published As

Publication number Publication date
EP3271476A1 (en) 2018-01-24
MX2017011910A (es) 2018-08-28
JP2018515128A (ja) 2018-06-14
US20200318192A1 (en) 2020-10-08
US20180094318A1 (en) 2018-04-05
EP3271476B1 (en) 2020-03-04
JP6751418B2 (ja) 2020-09-09
WO2016146811A1 (en) 2016-09-22
US11578368B2 (en) 2023-02-14
GB201504607D0 (en) 2015-05-06
ES2794950T3 (es) 2020-11-19

Similar Documents

Publication Publication Date Title
HK1249945A1 (zh) 使用區塊鏈對設備完整性的自動化認證
DK3812900T3 (da) Systemer, fremgangsmåder og apparater til heterogen beregning
DK3383482T3 (da) Systemer og fremgangsmåder til forebyggelse, mildnelse og/eller behandling af demens
DK3522851T3 (da) System til medicineringskompliansstyring.
DK3234152T3 (da) Svampegenommodificeringssystemer og anvendelsesfremgangsmåder
ZA201608122B (en) Disaster risk management and financing system, and corresponding method thereof
DK3265947T3 (da) Fremgangsmåde og system til kryptering
DK3234124T3 (da) Proteasevarianter og polynukleotider, som koder for dem.
DK3090416T3 (da) Fremgangsmåde og system til overvågning
DK3260813T3 (da) System og fremgangsmåde til afstandsbedømmelse
DK3271476T3 (da) Fremgangsmåder, værktøjer og systemer til vurdering, forebyggelse, styring og behandlingsvalg for type 2-diabetes
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3146035T3 (da) Biofilmmedier, behandlingssystem og behandlingsfremgangsmåde
DK3347014T3 (da) Fremgangsmåder til diagnosticering og behandling af Tourettes syndrom
DK3353168T3 (da) Forbindelser og fremgangsmåder til at inhibere jak
DK3406490T3 (da) Spildevandshåndteringssystem til køretøjer og tilhørende fremgangsmåde
DK3330258T3 (da) 1, 3, 5-triazinderivat og fremgangsmåde til anvendelse af samme
DK3359773T3 (da) Datasystemer, anordninger og fremgangsmåder
GB2537173B (en) Device and method for providing feedback on breathing rate.
DK3231131T3 (da) System og fremgangsmåde til at erstatte fælles identificerende data
DK3334693T3 (da) Kontinuerlig fremgangsmåde og system til behandlingen af spildevand
DK3093809T3 (da) Systemer og fremgangsmåder til tilstandsmaskinforvaltning
KR20180084908A (ko) 콘텐츠 관리 시스템, 및 콘텐츠 관리방법
DK3338642T3 (da) Ultralydsdiagnoseanordning og fremgangsmåde til styring af ultralydsdiagnoseanordning
DK3161412T3 (da) Fremgangsmåde og system til indeksering